← Mechanisms of action
CDK2/CDK4
PROTEIN FAMILYHomo sapiens
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| trilaciclib (Cosela) | Antagonist | approved | Small molecule | CDK2/CDK4 antagonist |
| arts-021 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| cyc065 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| incb0123667 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| inx-315 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| nuv-422 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| pf-06873600 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |
| syh2043 | Inhibitor | experimental | Small molecule | CDK2/CDK4 inhibitor |